Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Haberin özeti
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Güvenilir yayınların güncel haberlerini kısa açıklamalarıyla takip edin. Ayrıntılar için özgün kaynak bağlantısını açın.